A. H. Wu, K. D. Aaronson, S. F. Bolling, et al., “Impact of Mitral Valve Annuloplasty on Mortality Risk in Patients with Mitral Regurgitation and Left Ventricular Systolic Dysfunction,” Journal of the American College of Cardiology, Vol. 45, No. 3, 2005, pp. 381-387. doi:10.1016/j.jacc.2004.09.073

has been cited by the following article:

• TITLE: Impact of Mitral Valve Repair in Patients with End-Stage Congestive Heart Failure

  AUTHORS: John D. Nelson, Pierre Mikhael, Michael A. Wait, Bonnie J. Kuykendall, Kendall A. Nettle, Michael E. Jessen, Dan M. Meyer

  KEYWORDS: Mitral Valve Repair; Mitral Regurgitation; Heart Failure

  JOURNAL NAME: World Journal of Cardiovascular Surgery, Vol.2 No.4, December 27, 2012

  ABSTRACT: Objective: The utility of mitral valve repair in patients with Mitral Regurgitation (MR) and advanced CHF remains controversial. Methods: 37 patients with MR and Left Ventricular Ejection Fraction (LVEF) 25% as well as patients with LVIDd Results: Operative mortality was 0% for the group. There were significant reductions in NYHA Class (p = 0.0004), mitral regurgitation (p 25%. There were no significant differences in cardiac outcome changes between patients with LVIDd 25%, and between patients with LVIDd Conclusions: MV repair in patients with low LVEF and MR can be performed safely, with significant improvement in LVEF and symptom profile. No survival difference were noted between those patients with severely depressed LVEF or those with elevated ventricular dimensions (LVIDd) when compared to those with less severe but still significant cardiac impairment. Consideration should be given to these patients as an option prior to transplantation.